Skip to main content
. 2017 Feb 14;8:97. doi: 10.3389/fimmu.2017.00097

Table 1.

Patient information and sample use.

Patient Age Gender Cohort Analysis
1 NA F BA Ex vivo flow cytometry

2 NA M BA Ex vivo flow cytometry

3 NA F BA Ex vivo flow cytometry

4 NA F BA Ex vivo flow cytometry

6 NA F BA Ex vivo flow cytometry

7 51 M BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

8 40 M BA Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

9 40 F BA Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

10 63 F BA Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

11 51 F BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

12 36 M BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

13 40 F BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

14 60 F BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

15 44 M BA Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

16 NA F BA Ex vivo flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

17 53 M BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray

18 45 F BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray

20 59 M BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

21 60 F BA Ex vivo and in vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

22 38 M BA In vitro lymphoproliferation

23 59 F BA In vitro lymphoproliferation

24 56 F BA In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray

25 49 F BA In vitro apoptosis

26 57 M BA In vitro apoptosis

27 49 F BA In vitro flow cytometry, in vitro apoptosis in vitro lymphoproliferation

28 60 M BA In vitro flow cytometry, in vitro apoptosis in vitro lymphoproliferation, microarray

29 46 M BA In vitro apoptosis, in vitro lymphoproliferation, microarray

31 50 M BA In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray

32 50 F BA In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation, microarray

33 62 F BA In vitro flow cytometry, in vitro apoptosis, in vitro lymphoproliferation

2,569 27 F LI In vitro apoptosis

2,570 50 F LI In vitro apoptosis

2,574 35 F LI In vitro apoptosis

2,817 64 F LI Ex vivo flow cytometry

2,819 32 F LI Ex vivo flow cytometry

2,821 63 F LI Ex vivo flow cytometry

2,822 50 F LI Ex vivo flow cytometry

2,823 64 M LI Ex vivo flow cytometry

SP5 32 F SP Ex vivo flow cytometry

SP6 65 F SP Ex vivo flow cytometry

SP7 62 F SP Ex vivo flow cytometry

SP8 47 F SP Ex vivo flow cytometry

SP26 35 M SP Ex vivo flow cytometry

SP30 72 M SP Ex vivo flow cytometry

SP32 27 M SP Ex vivo flow cytometry

SP36 52 F SP Ex vivo flow cytometry

SP46 61 F SP Ex vivo flow cytometry

Cohorts: BA, Bahia; LI, Lima; SP, Sao Paulo.

NA, not available.